Investor Presentaiton
Investor presentation
Full year 2018
Slide 45
Poor diagnosis rates, lack of access to optimal treatment
and poor glycaemic control remain global problems
Diagnosis and optimal treatment
remains a challenge - the rule of halves
The worldwide challenge of glycaemic control:
Mean HbA1c in type 2 diabetes
All people with
diabetes
changing
diabetes
50% are diagnosed
100%
50%
25%
50% have access to
care
12%
50% get decent
care
50% reach target
Canada
USA
7.3%¹
7.2%²
Latin America 7.6%³
China 7.2-9.5%4
India 7.3-9.3%4
Japan 7.3-7.7%5
Korea
Russia
7.9-8.7%6
7.2-9.5%4
Germany
Greece
6.7-9.2%7
7.1-9.7%7,8,4
Italy
7.7-8.3%4
Poland
7.3-8.9%4
Portugal
7.9-9.7%7
Romania
7.9-9.9%7
Spain
7.6-9.2%8
Sweden
7.4-8.7%7
Turkey
UK
7.6-10.6%7
7.4-8.7%⁹
1 Harris et al. Diabetes Res Clin Pract 2005;70:90-7; 2 Hoerger et.al. Diabetes Care
2008;31:81-6; 3 Lopez Stewart et al. Rev Panam Salud Publica 2007;22:12-20;
4 Valensi et al. Int J Clin Pract 2009;63(3):522-31; 5 Arai et al. J Diabetes Investig. 2012
Aug 20;3(4): 396-401; 6 Ko et al. Diab Med 2007;24:55-62; 7 Oguz et al. Curr Med Res
Opin 2013;29:911-20; 8 Liebl et al. Diab Ther 2012;3:e1-10; 9 Blak et al. Diab Med
2012;29:e13-20
novo nordiskView entire presentation